Study suggests possible treatment for neurological disorder Rett syndrome

Using injections of a small derivate of the protein insulin-like growth factor-1 (IGF-1), scientists at Whitehead Institute for Biomedical Research and MIT's Picower Institute for Learning and Memory have successfully treated a mouse model of the devastating neurological disorder Rett syndrome.

If you want to include this story in your blog, copy and paste this formatted text: